Skip to content
MedsAcross

Brand family

Zortress

Everolimus · Novartis Pharmaceuticals
United States
Presentations
4
Markets
1

Zortress is a brand of Everolimus marketed by Novartis Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Everolimus
Brand owner
Novartis Pharmaceuticals
Registered in
United States
Strengths and forms
0.25 mg tablet, 0.5 mg tablet, 0.75 mg tablet, 1 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Zortress 0.25 mg tabletOralNovartis PharmaceuticalsUS FDAAvailable on request
Zortress 0.5 mg tabletOralNovartis PharmaceuticalsUS FDAAvailable on request
Zortress 0.75 mg tabletOralNovartis PharmaceuticalsUS FDAAvailable on request
Zortress 1 mg tabletOralNovartis PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Everolimus.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Zortress

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.